D16N (p.Asp16Asn) variant of DYSF (Dysferlin)

D16N (p.Asp16Asn) in DYSF (Dysferlin) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.74 / 1. The record also includes population frequency data and structural context.

D16N (p.Asp16Asn) variant details